ONHS Funding Opportunity Report
Solicitation ID: HDTRA125S0001
Agency: DTRA
The following entities may not participate as prime awardees nor furnish Principal Investigators (PIs) in awards made under this BAA but may act as collaborators, including as Co-PIs, and/or subawardees: ... Federal laboratories (including DoD and Department of Energy (DOE)). ... DOE-sponsored FFRDCs.
Note: This is an AI-generated summary...
The Defense Threat Reduction Agency (DTRA) has released a long-term Broad Agency Announcement (BAA), HDTRA1-25-S-0001, effective from FY2025 through FY2034, to fund fundamental (basic and applied) research aimed at countering chemical and biological (CB) Weapons of Mass Destruction (WMD). The primary focus is 'Fundamental Science for Chemical and Biological Defense' (Thrust Area 1), seeking to advance capabilities in detection, diagnostics, medical and material countermeasures, protection, and decontamination. This amendment introduces seven specific basic research topics (A1-A7) which include: drug-targeted delivery systems with monitoring; quantum computing for medical countermeasure development; oral microbiome analysis for presymptomatic diagnostics; threat-agnostic host response mechanisms; advanced materials for CB defense; quantum sensors; and triggered upconverting nanoparticles for detection. The submission process is two-phased, requiring a pre-application white paper (with pre-coordination generally required but waived for topics A1-A7) followed by an invited full proposal. DTRA anticipates awarding primarily grants of up to five years, with annual funding ranging from $25K to $1M, to a wide range of U.S. and foreign academic, industrial, and non-profit entities.
N/A
N/A
Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.
| Name | Score | Organization |
|---|---|---|
| Andrew Doran | 0.76 | ESA | ALS | Photon Science Development · Catalytic & Reactive Materials |
| Ashok Ajoy | 0.76 | ESA | CSD | Condensed Phase - CPIMS · Quantum Sensing Technologies |
| Sharon Greenblum | 0.75 | BSA | DOE Joint Genome Institute | JGI Technology Dept · Multi-Omic Host & Microbiome Analysis |
| Gerard Marriott | 0.75 | BSA | Molecular Biophysics & Integrated Bioimaging | Cellular & Tissue Image · Targeted Delivery & Monitoring Systems |
| Zachary Jones | 0.75 | BSA | Biological Systems & Engineering | Process Engr & Analytics · Quantum Biological Simulation |
| Ahmad Omar | 0.75 | ESA | MSD | Material Physics · Interface and Colloid Science |
| Qin Yu | 0.74 | ESA | MSD | Material Physics · Advanced Protective Materials |
| Maciej Haranczyk | 0.74 | CSA | AMCR | Computer Science · Computational Drug Discovery |
| Armand Alivisatos | 0.73 | ESA | MSD | Material Physics · Triggered Upconverting Nanoparticles |
| Siyun Chen | 0.73 | PSA | ATAP | BELLA Center · Optical Signal Amplification |
Per DoD policy1, ‘…products of fundamental research are to remain unrestricted to the maximum extent possible.’ Furthermore, ‘The DoD will place no other restrictions on the conduct or reporting of unclassified fundamental research, except as otherwise required by statue [sic], regulation, or Executive Order.’ As such, fundamental research is normally exempt from controls under the International Traffic in Arms Regulation (ITAR) (22 CFR Parts 120-130) and/or the Department of Commerce regarding the Export Administration Regulations (15 CFR Parts 730-774), but the DoD rule recognizes that there are “rare” situations where export-controlled information or technology may be used in fundamental research that may require a license(s) or restrictions on products.